Investment Summary |
|
|---|---|
| Date | 2019-07-31 |
| Target | Aperza |
| Sector | Internet Software and Services |
| Investor(s) | Eight Roads |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1969 |
| PE ASSETS | 11.0B USD |
| Size | Mega |
| Type | Sector Focused |
Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 218 of 293 |
| Sector: Internet Software and Services M&A | 50 of 60 |
| Type: Venture M&A Deals | 195 of 266 |
| Country: Japan M&A | 22 of 25 |
| Year: 2019 M&A | 17 of 21 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-07-29 |
StashAway
Singapore, Singapore StashAway is a wealth management platform design to build and protect your wealth. It personalizes financial planning and portfolio management for the vast range of needs of retail and accredited investors alike. StashAway was founded in 2016 and is based in Singapore. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-08-26 |
Modis Therapeutics
Oakland, California, United States Modis Therapeutics is a biopharmaceutical company focused on developing disease-modifying therapies for rare genetic diseases with a high unmet medical need. Modis program (MT1621) is in clinical development for TK2d, an inherited mitochondrial disease. Modis Therapeutics was founded in 2016 and is headquartered in Oakland, California, with offices in New York City. |
Sell | $250M |
